共 50 条
- [36] SAFETY OF VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE [J]. GASTROENTEROLOGY, 2017, 152 (05) : S585 - S585
- [38] Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 (07): : 896 - 903
- [39] vedolizumab trough levels at week 6 and 14 correlate with clinical remission in inflammatory bowel disease patients [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S492 - S492
- [40] Vedolizumab Levels During Induction Are Associated With Remission in Patients With Inflammatory Bowel Diseases [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S353 - S354